David Patience Accelerate Diagnostics, Inc (AXDX) insider trading activity

David Patience is Chief Financial Officer of Accelerate Diagnostics, Inc. Currently has a direct ownership of 64,568 shares of AXDX, which is worth approximately $645. The most recent transaction as insider was on Apr 01, 2025, when has been sold 6,816 shares (Common Stock) at a price of $0.71 per share, resulting in proceeds of $4,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 64.6K

0% 3M change

28.06% 12M change

Total Value Held $645

David Patience Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	SELL Open market or private sale	$4,839 $0.71 p/Share	6,816 Reduced 9.55%	64,568 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	-	20,000 Added 21.89%	71,384 Common Stock
Feb 26 2025	SELL Open market or private sale	$583 $1.09 p/Share	535 Reduced 1.03%	51,384 Common Stock
Feb 26 2025	BUY Exercise of conversion of derivative security	-	1,500 Added 2.81%	51,919 Common Stock
Apr 09 2024	SELL Open market or private sale	$11,567 $0.87 p/Share	13,296 Reduced 20.87%	50,419 Common Stock
Apr 09 2024	BUY Exercise of conversion of derivative security	-	37,468 Added 37.03%	63,715 Common Stock
Feb 26 2024	SELL Open market or private sale	$336 $0.96 p/Share	350 Reduced 1.32%	26,247 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	1,000 Added 3.62%	26,597 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	16,666 Added 39.43%	25,597 Common Stock
Dec 13 2023	SELL Open market or private sale	$425 $4.39 p/Share	97 Reduced 1.07%	8,931 Common Stock
Dec 13 2023	BUY Exercise of conversion of derivative security	-	331 Added 3.54%	9,028 Common Stock
Nov 13 2023	SELL Open market or private sale	$540 $5.57 p/Share	97 Reduced 1.1%	8,697 Common Stock
Nov 13 2023	BUY Exercise of conversion of derivative security	-	331 Added 3.63%	8,794 Common Stock
Oct 13 2023	SELL Open market or private sale	$559 $5.83 p/Share	96 Reduced 1.12%	8,463 Common Stock
Oct 13 2023	BUY Exercise of conversion of derivative security	-	331 Added 3.72%	8,559 Common Stock
Sep 13 2023	SELL Open market or private sale	$626 $6.53 p/Share	96 Reduced 1.15%	8,228 Common Stock
Sep 13 2023	BUY Exercise of conversion of derivative security	-	331 Added 3.82%	8,324 Common Stock
Aug 14 2023	SELL Open market or private sale	$646 $6.8 p/Share	95 Reduced 1.17%	7,993 Common Stock
Aug 13 2023	BUY Exercise of conversion of derivative security	-	331 Added 3.93%	8,088 Common Stock
Jul 13 2023	SELL Open market or private sale	$634 $6.9 p/Share	92 Reduced 1.17%	7,757 Common Stock
Jul 13 2023	BUY Exercise of conversion of derivative security	-	330 Added 4.03%	7,849 Common Stock
Jun 13 2023	SELL Open market or private sale	$1,158 $0.9 p/Share	1,287 Reduced 1.68%	75,192 Common Stock
Jun 13 2023	BUY Exercise of conversion of derivative security	-	3,309 Added 4.15%	76,479 Common Stock
May 15 2023	SELL Open market or private sale	$843 $0.69 p/Share	1,222 Reduced 1.64%	73,170 Common Stock
May 15 2023	BUY Exercise of conversion of derivative security	-	3,309 Added 4.26%	74,392 Common Stock

Also insider at

MTACW

MedTech Acquisition Corp

Chief Financial Officer

David Patience

Chief Financial Officer

Tucson, AZ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXDX shares.

Notify only if

Value

Insider Trading

Get notified when an Accelerate Diagnostics, Inc insider buys or sells AXDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Accelerate Diagnostics, Inc

Track Activities on AXDX

Account